Candel Therapeutics, Inc. (CADL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Candel Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -7.84x | -4.98x | -1.12x | -2.75x | -6.21x | -7.41x |
| P/B Ratio | 5.76x | 4.15x | 3.34x | 1.08x | 3.50x | -5.56x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 412.75x | 1794.84x | 1048.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 100.0% | -11575.2% | 100.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | -27777.6% | -20580.8% | -11048.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | -15035.2% | -28899.2% | -14144.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | -13046.4% | -20395.2% | -10975.2% |
| Liquidity | ||||||
| Current Ratio | 13.31x | 2.77x | 2.59x | 12.81x | 15.84x | 7.46x |
| Quick Ratio | 13.31x | 2.77x | 2.59x | 12.81x | 15.84x | 7.46x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.20x | 1.79x | 0.48x | 0.01x | -0.04x |
YoY = year-over-year change. Source: FMP..